Janet M. Pavese, Ph.D.
Affiliations: | 2014 | Life Sciences | Northwestern University, Evanston, IL |
Area:
OncologyGoogle:
"Janet Pavese"Mean distance: (not calculated yet)
Parents
Sign in to add mentorRaymond C. Bergan | grad student | 2014 | Northwestern | |
(Mitogen-Activated Protein Kinase Kinase 4 (MEK4) Promotes Human Prostate Cancer Invasion and Metastasis.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Xu L, Gordon R, Farmer R, et al. (2018) Precision therapeutic targeting of human cancer cell motility. Nature Communications. 9: 2454 |
Pavese JM, Ogden IM, Voll EA, et al. (2014) Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis. Plos One. 9: e102289 |
Pavese JM, Bergan RC. (2014) Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapy. Cancer Letters. 352: 179-86 |
Pavese JM, Krishna SN, Bergan RC. (2014) Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis. The American Journal of Clinical Nutrition. 100: 431S-6S |
Voll EA, Ogden IM, Pavese JM, et al. (2014) Heat shock protein 27 regulates human prostate cancer cell motility and metastatic progression. Oncotarget. 5: 2648-63 |
Pavese J, Ogden IM, Bergan RC. (2013) An orthotopic murine model of human prostate cancer metastasis. Journal of Visualized Experiments : Jove. e50873 |
Xu L, Farmer R, Huang X, et al. (2012) Abstract 4752: Selective inhibition of cancer metastasis with a novel small therapeutic molecule Cancer Research. 72: 4752-4752 |
Pavese JM, Ogden I, Huang X, et al. (2012) Abstract 3277: Increased mitogen-activated protein kinase kinase 4 (MEK4) induces metastasis in an orthotopic murine model of prostate cancer Cancer Research. 72: 3277-3277 |
Pavese JM, Ogden IM, Huang X, et al. (2011) Abstract 1407: Mitogen-activated protein kinase kinase 4 (MEK4) is a key regulator of prostate cancer progression Cancer Research. 71: 1407-1407 |
Xu L, Farmer R, Huang X, et al. (2011) Abstract C177: Chemical-driven biological probing: Discovery of a novel antimetastatic drug. Molecular Cancer Therapeutics. 10 |